How we spend your money

scientists in lab

Get the annual report

Review our performance for the year, the progress we're making against our objectives and our aims for the future.

Download the report

See how your donations make a lasting impact. Every year, Cancer Research UK's annual report is published. It hosts a wealth of information about how we strive to bring forward the day when all cancers are cured. The report also includes how we spent money raised through donations and support. It's available for everyone to download, but if you're looking for a quick breakdown of where your donation goes, this page has got you covered.

photo of Michelle Mitchell
This has not been a normal financial year. And while we have a harder job to do now in light of COVID-19, we are absolutely determined to continue our research to create better treatments for tomorrow.
      - Michelle Mitchell, Chief Executive
 
 

Our income

In 2019/2020, we raised a total of £656m

We couldn't have done this without our amazing supporters, volunteers and campaigners. This includes:

  • £423 from donated income, including legacies (£184m) and events (£48m)
  • £108m from trading activities such as our shops
  • £7m from our portfolio of investments
  • £118m from royalties and grants, including our share of sales from innovations developed from our research
Infographic describing what we raised and how we spent it

Our expenditure

Every pound is important. So we think very carefully about where we spend our income and what we commit our money to. 

We committed £511m of our income towards our charitable activities

  • We committed £468m towards cancer research projects that will run for up to five years
  • We spent £42m on our information and influencing work

We also invested £193m in raising funds, including:

  • £93m raising donated income
  • £98m running our shops and other trading activity
  • £2m managing our investments

The research we fund

We fund cancer research into all types of cancer

The amount we spend varies year to year as we don’t allocate all of our resources ahead of time.

In 2019/2020, we committed £468m to cancer research, that will fund new projects that will run for many years. We spent £455m on ongoing research activity, including projects started in previous years.

The graphics below show that we spent:

  • £203m on research into specific cancers
  • £86m on research into cancer’s fundamental biology
  • £81m on research relevant to all cancers, including our network of centres and clinical trials units
  • £43m passed on to other research organisations, as their share of the royalties we received from sales of innovations developed from previous research
  • £42m on research administration and support, including the systems and processes that allow us to fund world-class research
Infographic describing our online research funding
Infographic describing our online research spending
infographic breaking down spending by pence in the pound

Pence in the pound

The graphic to the left shows that for every pound of income from donations, investments and royalties, 83p was available to beat cancer. The amount available varies from year to year, but we aim to keep it around the 80p mark.

We don’t include our trading activities in this calculation, as our shops operate like other retail businesses, raising funds through selling merchandise. According to the 2018 Charity Shops Survey, our network of shops delivered the best profit ratio of any large UK charity retailer.

[Source: Charity Shops Survey 2018]

!

Content not working due to cookie settings.

Manage your cookie settings here

 

Supporting documents

We are committed to supporting high-quality cancer research that will have the greatest impact for patients and help save more lives. The host institution list is an analysis of grant costs by host institution which forms part of our audited accounts.

Some of our scientists both serve on our grant-making committees and lead research projects that receive grant funding from Cancer Research UK during the year.

Our previous annual reports